APO DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Apollo Global Management, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – APO April 12, 2026
NAVN FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Navan, Inc. Investors to Secure Counsel Before Important April 24 Deadline in Securities Class Action – NAVN April 12, 2026
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Super Micro Computer, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SMCI April 12, 2026
ROSEN, THE FIRST FILING FIRM, Encourages Trip.com Group Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TCOM April 12, 2026
Trillion Dollar Robot Under Investigation: New 2026 Report Highlights Nvidia AI Expansion, Autonomous Trucking Breakthroughs, and Rapid Expansion of Robotics Infrastructure April 11, 2026
AI’s Second Wind Is Here — Weiss Ratings Plus Report Cites 303% Historical Average and 2026 Data Signals Pointing Beyond the First AI Cycle April 11, 2026
Safe Money Report Under Investigation: Martin Weiss’s 2026 “Age of Chaos” Report Outlines Six-Step Framework Addressing Dollar Instability, Gold, and Bitcoin Amid Rising Market Volatility April 11, 2026
Safe Money Report Claims Evaluated: Health Bomb Analysis by Weiss Ratings Examines Healthcare Cost Pressures, Defensive Investment Strategies, and Economic Risk Factors for 2026 April 11, 2026
Wealth Megatrends Under Investigation: Gold’s Hidden 5x Paradox — Weiss Ratings’ 2026 Report Identifies End of Nine-Year Silver Mining Suppression as Precious Metals Cycle Enters a New Phase April 11, 2026
Upcoming National Women’s Health Week: Promoting Scalp Care and Breathable Wig Solutions April 11, 2026
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer April 11, 2026
KWM Menandatangani Perjanjian Pengedaran Eksklusif Global dengan HYBE yang Merangkumi BTS, SEVENTEEN, LE SSERAFIM dan Lain-lain — Menyasarkan Pendapatan Tahunan Melebihi AS$100 Juta April 11, 2026
NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification April 11, 2026
